AMNEAL PHARMACEUTICALS, INC. Noncash or Part Noncash Acquisition, Intangible Assets Acquired
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Noncash or Part Noncash Acquisition, Intangible Assets Acquired of $12.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 · last filed 2026-08-06
- AMNEAL PHARMACEUTICALS, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2026-06-30 was $10.75M, a 102.87% increase year-over-year.
- AMNEAL PHARMACEUTICALS, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2026-03-31 was $1.35M, a 20.59% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2025-06-30 was $5.30M.
- AMNEAL PHARMACEUTICALS, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2025-03-31 was $1.70M.
| Period end | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 6 month |
|---|---|---|
| 2026-06-30 | $10.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $12.10M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.35M 10-Q · filed 2026-05-07 | |
| 2025-06-30 | $5.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $7.00M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $1.70M 10-Q · filed 2026-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |